Sorry, you need to enable JavaScript to visit this website.
  1. Home
  2. Our Science
  3. Clinical Trials
  4. Plain Language Study Results Summaries

Plain Language Study Results Summaries

What Are Plain Language Study Results Summaries?

Plain Language Study Results Summaries are descriptions in everyday language of the design and results of clinical studies. These summaries, also called plain language summaries, simple summaries, and trial results summaries, are intended to make clinical results understandable and accessible to patients, healthcare providers, caregivers, researchers, and a general audience.

Please use the search function below to find Plain Language Study Results Summaries for Pfizer-sponsored global clinical trials.

Filter Results

Refine your search results by using the dropdown filters below. Click “reset” to return to the full list of available studies.

Clinical Trial to Assess Use of a New Meningitis Vaccine (MenABCWY) in Participants Aged 10 to 25 Years
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PF-05212366 (Bivalent rLP2086)
Language: English
ViewDownloadPrint
Kliininen tutkimus uuden aivokalvotulehdusrokotteen (MenABCWY) arvioimiseksi 10–25-vuotiailla osallistujilla
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PF-05212366 (Bivalent rLP2086)
Language: Finnish
ViewDownloadPrint
A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).
Category & Conditions: Immune System Diseases and Conditions
Study Phase : 3
Medicine: PF-06410293
Language: English
ViewDownloadPrint
Persistence of Antibodies After Meningococcal Vaccine PF-06866681 in Healthy Children
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: Nimenrix (meningococcal serogroups A, C, W-135 and Y conjugate vaccine)
Language: English
ViewDownloadPrint
The Long-term Antibody Persistence of MenACWY-TT Vaccine (PF-06866681) Versus Meningitec or Mencevax ACWY in Healthy Adolescents and Adults and a Booster Dose of MenACWY-TT Administered 10 Years Post Primary Vaccination
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: Nimenrix (meningococcal serogroups A, C, W-135 and Y conjugate vaccine)
Language: English
ViewDownloadPrint
Study to Evaluate Long-term Antibody Persistence of GlaxoSmithKline Biologicals' MenACWY-TT Vaccine (GSK134612) Vs Mencevax ACWY in Healthy Adolescents and Adults and Booster Response to MenACWY-TT Vaccine Administered at 10 Years Post-primary Vaccination
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: Nimenrix (meningococcal serogroups A, C, W-135 and Y conjugate vaccine)
Language: English
ViewDownloadPrint
Tutkimus, jossa tarkastellaan terveiden vauvojen vastetta Nimenrix-rokotteelle
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: Nimenrix (meningococcal serogroups A, C, W-135 and Y conjugate vaccine)
Language:
ViewDownloadPrint
Study Looking at Response to the Nimenrix Vaccine in Healthy Infants
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: Nimenrix (meningococcal serogroups A, C, W-135 and Y conjugate vaccine)
Language: English
ViewDownloadPrint
Immunogenicity and Safety Study of 1 and 2 Doses of Meningococcal Vaccine MenACWY-TT in Toddlers, Persistence up to 5 Years After Vaccination and Co-administration With Pfizer's Prevenar 13® Vaccine
Category & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: Nimenrix (meningococcal serogroups A, C, W-135 and Y conjugate vaccine), PREVNAR 13(PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE [DIPHTHERIA CRM197 PROTEIN])
Language: English
ViewDownloadPrint
Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs)
Category & Conditions: Infections and Infectious Diseases
Study Phase : 2
Medicine: Zavicefta (ceftazidime-avibactam)
Language: English
ViewDownloadPrint
Evaluation of Safety, Pharmacokinetics and Efficacy of Ceftazidime and Avibactam (CAZ-AVI ) Compared With Cefepime in Children From 3 Months to Less Than 18 Years of Age With Complicated Urinary Tract Infections (cUTIs)
Category & Conditions: Infections and Infectious Diseases
Study Phase : 2
Medicine: Zavicefta (ceftazidime-avibactam)
Language: English
ViewDownloadPrint
A Study of Ceftazidime-Avibactam in Newborns and Infants Less Than 3 Months Old With Suspected or Confirmed Infections Due to Gram-Negative Bacteria That Needed Intravenous Antibiotic Treatment
Category & Conditions: Infections and Infectious Diseases
Study Phase : 2
Medicine: Zavicefta (ceftazidime-avibactam)
Language: English
ViewDownloadPrint